Newsbenzinga
Jim Cramer Senses a 'Fake Out' in Rumored AstraZeneca, Bristol Myers Squibb $400 Billion Mega-Merger
· Published
Article summary
Jim Cramer senses a 'fake out' in the rumored $400B AstraZeneca and Bristol Myers Squibb mega-merger. Read why he thinks BMY 'needs help'.
An excerpt from the original article.
Comments —
Loading comments…